DE69710879D1 - Arzneimittel auf basis von progesteron und östradiol - Google Patents

Arzneimittel auf basis von progesteron und östradiol

Info

Publication number
DE69710879D1
DE69710879D1 DE69710879T DE69710879T DE69710879D1 DE 69710879 D1 DE69710879 D1 DE 69710879D1 DE 69710879 T DE69710879 T DE 69710879T DE 69710879 T DE69710879 T DE 69710879T DE 69710879 D1 DE69710879 D1 DE 69710879D1
Authority
DE
Germany
Prior art keywords
pct
oil
progesterone
östradiol
dissolve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69710879T
Other languages
English (en)
Other versions
DE69710879T2 (de
Inventor
Dominique Salin-Drouin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Besins Iscovesco SA
Original Assignee
Laboratoires Besins Iscovesco SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Besins Iscovesco SA filed Critical Laboratoires Besins Iscovesco SA
Publication of DE69710879D1 publication Critical patent/DE69710879D1/de
Application granted granted Critical
Publication of DE69710879T2 publication Critical patent/DE69710879T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
DE69710879T 1996-04-05 1997-04-04 Arzneimittel auf basis von progesteron und östradiol Expired - Lifetime DE69710879T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9604349A FR2747042B1 (fr) 1996-04-05 1996-04-05 Medicament a base de progesterone et d'oestradiol
PCT/FR1997/000612 WO1997037642A1 (fr) 1996-04-05 1997-04-04 Medicament a base de progesterone et d'oestradiol

Publications (2)

Publication Number Publication Date
DE69710879D1 true DE69710879D1 (de) 2002-04-11
DE69710879T2 DE69710879T2 (de) 2002-11-14

Family

ID=9490985

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69710879T Expired - Lifetime DE69710879T2 (de) 1996-04-05 1997-04-04 Arzneimittel auf basis von progesteron und östradiol

Country Status (9)

Country Link
US (1) US6077531A (de)
EP (1) EP0896529B1 (de)
JP (1) JP2000508309A (de)
AT (1) ATE213934T1 (de)
CA (1) CA2251002C (de)
DE (1) DE69710879T2 (de)
ES (1) ES2172782T3 (de)
FR (1) FR2747042B1 (de)
WO (1) WO1997037642A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028057A (en) * 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
FR2777784B1 (fr) * 1998-04-27 2004-03-19 Arepa Composition pharmaceutique a base d'estrogene et de progesterone
US6544553B1 (en) * 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
FR2832065B1 (fr) * 2001-11-13 2004-11-05 Besins Int Belgique Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations
EP1474069A1 (de) 2002-02-08 2004-11-10 Advanced Animal Technology Limited Kontrolle einer biologischen funktion
EP1844765B1 (de) 2003-06-13 2015-01-21 Skendi Finance, Ltd. Langsam freisetzende estradiol-progesterone formulierung
WO2005035717A2 (en) 2003-10-03 2005-04-21 Thorn Bioscience, Llc Process for the synchronization of ovulation for timed breeding without heat detection
US8075910B2 (en) * 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
EP2421545B1 (de) 2009-04-23 2017-12-06 JBS United Animal Health II LLC Verfahren und vorrichtung zur synchronisierung der befruchtungszeit
WO2011073995A2 (en) 2009-12-14 2011-06-23 Lincoln Pharmaceuticals Limited Liquid vaginal spray of progesterone
UY33103A (es) 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
CN113398243A (zh) 2012-11-28 2021-09-17 联合动物健康第二有限责任公司 用于同步小母猪的授精时间的方法
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
JP2017523138A (ja) 2014-07-29 2017-08-17 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 経皮クリーム
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4624665A (en) * 1984-10-01 1986-11-25 Biotek, Inc. Method of transdermal drug delivery
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
RU2134105C1 (ru) * 1993-06-18 1999-08-10 Смитклайн Бичам Корпорейшн Мягкая желатиновая капсула

Also Published As

Publication number Publication date
JP2000508309A (ja) 2000-07-04
FR2747042A1 (fr) 1997-10-10
CA2251002A1 (fr) 1997-10-16
FR2747042B1 (fr) 1998-06-05
DE69710879T2 (de) 2002-11-14
WO1997037642A1 (fr) 1997-10-16
ATE213934T1 (de) 2002-03-15
ES2172782T3 (es) 2002-10-01
EP0896529A1 (de) 1999-02-17
EP0896529B1 (de) 2002-03-06
US6077531A (en) 2000-06-20
CA2251002C (fr) 2007-01-30

Similar Documents

Publication Publication Date Title
DE69710879T2 (de) Arzneimittel auf basis von progesteron und östradiol
DE59604603D1 (de) Arzneiform zur abgabe von wirkstoffen an wunden
DE69328550D1 (de) Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln
DE19581906T1 (de) Lokale Abgabe bzw. Zuführung und Überwachung von Arzneimitteln
DE69204162T2 (de) Zusammensetzung auf der basis von silikon und latex zur behandlung von keratinösen substanzen.
DE69414558T2 (de) Gerät und methode für den lokalen auftrag von polymermaterial auf gewebe
FR2701844B1 (fr) Association epaississante a base de gomme de guar ou de cellulose non ionique, sans groupe hydrophobe et d'un polymere reticule, et application pour le traitement des cheveux ou de la peau contenant une telle association.
DE69305328D1 (de) Mikrokapseln mit wänden aus primären alkoholfunktionen enthaltenden polysacchariden, und zusammensetzungen daraus
DE69228997D1 (de) Menschliche il-3-varianten
ATE213630T1 (de) Verwendung vonsisovaleramid als mildes anxiolytisches und sedatives mittel
FR2731907B1 (fr) Composition dermatologique et/ou cosmetique depigmentante et utilisation dans une methode cosmetique
DE69711078T2 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
DE69328193D1 (de) Verwendung von prodelphidinen zur behandlung von arthrose
DE59100496D1 (de) Verwendung von selektiv hydrierten Styrol-Butadien-Copolymerisaten in kosmetischen und pharmazeutischen Zubereitungen.
NO981265D0 (no) Nye, vannsvellbare preparater av guar-gummi og guar-gummi-derivater i oleofile væsker samt deres anvendelse
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
ATE135223T1 (de) Arzneimittel zur behandlung von hyperlipidämie und/oder atherosklerose
AU3851095A (en) Assay
NO984651D0 (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
ATE207756T1 (de) Pharmazeutische zusammensetzung, die muirapuama und pflanzenwürmer enthaelt
FR2718024B1 (fr) Médicament et composition pharmaceutique pour le traitement de l'inflammation.
Willcox Health scare
ATE309807T1 (de) Zusammensetzung zur behandlung von atherosklerose,welche ein statin und ex-vivo behandeltes blut enthält
ATE291904T1 (de) 2,4-dichlorbenzylalkohol und amylmetakresol gegen hiv-infektion
NO975155L (no) Anvendelse av forskolin eller ekstakter inneholdende denne ved fremstilling av et medikament for behandling av alkoholavhengighet

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: PATENTANWAELTE VON KREISLER, SELTING, WERNER ET CO